Corticosteroid bioavailability assays. Correlation with a clinical study.
D000085:Acetates; D001681:Biological Assay; D001702:Biopharmaceutics; D003436:Croton Oil; D004304:Dosage Forms; D004339:Drug Compounding; D004357:Drug Synergism; D004952:Esters; D005069:Evaluation Studies as Topic; D005233:Fatty Alcohols / Q000494:pharmacology; D005446:Fluocinolone Acetonide / Q000494:pharmacology* / Q000627:therapeutic use; D006801:Humans; D008722:Methods; D009824:Ointments; D014677:Pharmaceutical Vehicles; D010919:Placebos; D011409:Propylene Glycols / Q000494:pharmacology; D011565:Psoriasis / Q000175:diagnosis / Q000188:drug therapy; D012867:Skin / Q000187:drug effects; D012871:Skin Diseases / Q000188:drug therapy; D012882:Skin Tests; D013997:Time Factors; D014466:Ultraviolet Rays; D014662:Vasoconstrictor Agents
D000085:Acetates; D004304:Dosage Forms; D004952:Esters; D005233:Fatty Alcohols; D009824:Ointments; D014677:Pharmaceutical Vehicles; D010919:Placebos; D011409:Propylene Glycols; D014662:Vasoconstrictor Agents; D005446:Fluocinolone Acetonide; D003436:Croton Oil